HealthQuill cancer diagnosis
AstraZeneca and Daiichi Sankyo’s breast cancer drug, Enhertu, has cut the risk of disease progression or death by 44% compared to a taxane, trastuzumab and pertuzumab combination. 
Drugs Health Pharma

AstraZeneca, Daiichi’s Enhertu cuts breast cancer progression by 44%

HQ Team June 3, 2025: AstraZeneca and Daiichi Sankyo’s breast cancer drug, Enhertu, has cut the risk of disease progression or death by.

Read More
Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency for Research on Cancer, a specialised arm of the World Health Organization.
Drugs Health Pharma

Breast cancer death rates globally to rise 68% by 2050: WHO arm IARC warns

Annual deaths caused by breast cancer globally will rise 68% to 1.1 million by 2050, according to a report from the International Agency.

Read More
Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.
Drugs Health Medical

Study finds unexpected link between weight loss and cancer risk

HQ Team March 4, 2024: Obesity is widely recognized as a risk factor for cancer, and a recent study sheds light on an.

Read More
Notre Dame University exRNA deivce
Drugs Health Medical Pharma

Revolutionary device decodes RNA for faster diagnosis of cancer

HQ Team October 26, 2023: Scientists at the University of Notre Dame have developed an innovative device that can decode the messages exchanged.

Read More